Clinical Trials for Drug: Cytoxan

2 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
ECOG-E1910 (CIRB) A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-negative B lineage Acute Lymphoblastic Leukemia in Adults Open
UCI-13-14 A Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study of (ERC1671/ GM-CSF / Cyclophosphamide) + Bevacizumab versus (Placebo Injection / Placebo pill) + Bevacizumab in the Treatment of Recurrent/Progressive, Bevacizumab Naïve Glioblastoma Multiforme and Gliosarcoma Patients (WHO Grade IV Malignant Gliomas) Open